The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: Bevacizumab     Injury: Proteinuria     Quarter: 2016Q3

Total Records: 29     Number of Pages: 2

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
81331126 Bevacizumab Proteinuria ROCHE 0.00 F 0 20160912 US
104009286 Bevacizumab Proteinuria ROCHE 0.00 0 20160916 DE
115525913 Bevacizumab Proteinuria ROCHE 0.00 0 20160810 JP
116482953 BEVACIZUMAB Proteinuria MERCK 7.00 YR F 0 20160706 GB
122161853 Bevacizumab Proteinuria ROCHE 0.00 0 20160907 JP
125268391 Bevacizumab Proteinuria CIPLA 0.00 0 20160705 US
125392701 Bevacizumab Proteinuria CIPLA 0.00 0 20160708 US
125393161 Bevacizumab Proteinuria CIPLA 0.00 0 20160708 BE
125483631 BEVACIZUMAB Proteinuria MERCK 0.00 0 20160712 US
125515651 Bevacizumab Proteinuria CIPLA 0.00 0 20160713 US
125620512 BEVACIZUMAB Proteinuria MERCK 0.00 0 20160725 US
126096861 Bevacizumab Proteinuria ROCHE 0.00 0 20160801 CN
126171041 Bevacizumab Proteinuria ROCHE 0.00 0 20160803 FR
126626232 Bevacizumab Proteinuria ROCHE 0.00 F 0 20160912 CN
126665311 Bevacizumab Proteinuria ROCHE 74.44 YR M 0 20160819 BE
126692271 BEVACIZUMAB Proteinuria BAYER 15.00 YR M 0 20160819 TR
126759101 Bevacizumab Proteinuria ROCHE 63.00 YR M 0 20160823 FR
126838491 Bevacizumab Proteinuria ROCHE 0.00 0 20160825 ES
126869531 Bevacizumab Proteinuria ROCHE 0.00 0 20160826 ES
126883782 Bevacizumab Proteinuria ROCHE 0.00 0 20160828 CN

Total Records: 29     Number of Pages: 2